PHILADELPHIA — In a subgroup analysis of the IMPROVE-IT trial, which included patients with recent ACS on statin therapy, those with diabetes benefited most from the addition of ezetimibe compared with those without diabetes.
The greater benefit observed in patients with diabetes was driven by reductions in MI and ischemic stroke, Robert P. Giugliano, MD, SM, FACC, FAHA, cardiovascular medicine specialist at Brigham and Women’s Hospital and senior investigator with the Thrombolysis in Myocardial Infarction (TIMI) Study Group, said during a presentation at the third annual Heart in
Anupam Ghose, a physician by training, was diagnosed with Type 2 Diabetes Mellitus (T2DM) in 2017. After the diagnosis of T2DM, he followed a low carbohydrate high fat diet and reversed his T2DM within a year. Now he has one main goal in life. Yes, it is to make people understand that the conventional method of treating T2DM is not beneficial. The best way to reverse T2DM is through diet and lifestyle modification. He decided to help people suffering from T2DM in their new journey by offering consultations and working together with them in order to achieve a T2DM free life.